Medtronic plc
CH ˙ SWX ˙ IE00BTN1Y115
SecurityCH:MDT / Medtronic plc
InstitutionPalouse Capital Management, Inc.
Latest Disclosed Ownership27,752 shares
Latest Disclosed Value $ 2,404,711
Palouse Capital Management, Inc. reports 5.69% decrease in ownership of MDT / Medtronic plc

On April 24, 2026 - Palouse Capital Management, Inc. filed a 13F-HR form disclosing ownership of 27,752 shares of Medtronic plc (CH:MDT) valued at $2,404,711 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 23, 2026 disclosing 29,425 shares of Medtronic plc. This represents a change in shares of -5.69% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-24 2026-03-31 13F MEDTRONIC SHS G5960L103 27,752 -1,673 -5.69 2,405 -14.93 1.5900
2026-01-23 2025-12-31 13F MEDTRONIC SHS G5960L103 29,425 -997 -3.28 2,827 -2.45 1.8112
2025-10-23 2025-09-30 13F MEDTRONIC SHS G5960L103 30,422 -29 -0.10 2,897 9.16 1.8427
2025-08-07 2025-06-30 13F Medtronic SHS G5960L103 30,451 37 0.12 2,654 -2.89 1.7509
2025-04-16 2025-03-31 13F Medtronic SHS G5960L103 30,414 -221 -0.72 2,733 11.69 1.8652
2025-01-30 2024-12-31 13F Medtronic SHS G5960L103 30,635 -374 -1.21 2,447 -12.33 1.6273
2024-10-21 2024-09-30 13F/A-1 MEDTRONIC SHS G5960L103 31,009 4,810 18.36 2,792 35.35 1.7632
2024-10-21 2024-09-30 13F MEDTRONIC SHS G5960L103 31,009 4,810 2,792 1.7632
2024-08-12 2024-06-30 13F MEDTRONIC SHS G5960L103 26,199 -425 -1.60 2,062 -11.12 1.3841
2024-05-15 2024-03-31 13F MEDTRONIC SHS G5960L103 26,624 -1,614 -5.72 2,320 -0.26 1.5319
2024-01-31 2023-12-31 13F MEDTRONIC INC SHS G5960L103 28,238 -888 -3.05 2,326 1.93 1.6448
2023-10-23 2023-09-30 13F MEDTRONIC INC SHS G5960L103 29,126 -566 -1.91 2,282 -12.73 1.6942
2023-08-09 2023-06-30 13F MEDTRONIC INC SHS G5960L103 29,692 -770 -2.53 2,616 6.52 1.8282
2023-05-15 2023-03-31 13F MEDTRONIC INC SHS G5960L103 30,462 30,462 2,456 1.6555
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.